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Endovenous ablation of incompetent perforating
veins is effective treatment for recalcitrant venous
ulcers
Peter F. Lawrence, MD, Ali Alktaifi, MD, David Rigberg, MD, Brian DeRubertis, MD, Hugh Gelabert,
MD, and Juan Carlos Jimenez, MD, Los Angeles, Calif
Objectives: Endovenous closure of incompetent saphenous veins has been reported to facilitate venous ulcer healing;
however, there is little information about the effectiveness of perforator ablation (PA) in healing recalcitrant venous
ulcers. We report our experience with PA with venous ulcers unresponsive to prolonged compression therapy.
Methods: Patients with nonhealing venous ulcers of >3 months’ duration underwent duplex ultrasound to assess their
lower extremity venous system for incompetence of superficial, perforating, and deep veins. Patients who had either no
saphenous incompetence or persistent ulcers after saphenous ablation underwent PA of incompetent perforating veins>3
mm that demonstrated reflux; initial treatment was performed on the perforator vein adjacent to the ulcer with additional
incompetent veins treated if ulcer healing failed.
Results: Seventy-five ulcers with 86 associated incompetent perforating veins were treated with PA in 45 patients with
CEAP 6 recalcitrant venous ulcers. Treated incompetent perforator veins were located in the medial ankle (61%), calf
(37%), and lateral ankle (2%). Initial success of PA, assessed by postprocedure duplex ultrasound, was 58%; repeat
ablation was 90% successful and 71% had eventual successful perforator closure. No complications (skin necrosis,
infection, or nerve injury) occurred. Failure of ulcer healing with successful perforator closure occurred in 10% and was
due to intercurrent illness, patient noncompliance, and patient death due to unrelated causes. Of patients who healed
their ulcers, the healing occurred at a mean of 138 days; an average PA of 1.5 incompetent veins per ulcer was required
for healing. Ninety percent of ulcers healed when at least one perforator was closed; no ulcer healed without at least one
perforator being closed.
Conclusions:This experience demonstrates both the feasibility and effectiveness of PA for a selected group of patients with
venous ulcers who fail conventional therapy with compression. (J Vasc Surg 2011;54:737-42.)
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aIncompetent perforating veins have been implicated in
the development of venous ulcers since the relationship was
first proposed by Homans in 1916.1 Procedures to elimi-
nate incompetence and reflux in the perforating veins have
been advocated using surgical ligation,2 subfascial surgical
approaches,3 and sclerotherapy.4 The approach has shifted
towardminimally invasive techniques, due to the fragility of
the skin around the ulcer and the risk of creating new
nonhealing wounds with surgical procedures.
Recently, endovascular ablation has been advocated to
close refluxing perforating veins.5 Endovenous ablation
reports have demonstrated good technical success and low
complication rates,6 although most reports have focused
primarily on successful ablation of the vein, rather than
venous ulcer healing.
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doi:10.1016/j.jvs.2011.02.068We conducted this study to evaluate patients who had
hronic venous ulcers that had received optimal therapy
ith compression and wound care for at least 3 months and
herefore were considered to be refractory to conventional
reatment. These patients were optimal candidates for our
tudy to determine the impact of perforator ablation on the
ealing of recalcitrant venous ulcers.
ETHODS
Patients with venous ulcers were evaluated for treat-
ent in the Gonda Wound Care Center at UCLA. Some
atients had undergone procedures at outside facilities but
one had undergone endovenous ablation of perforating
eins before evaluation and treatment in our program.
As part of the initial evaluation at the wound care
enter, all patients underwent a medical history and physi-
al examination, ankle-brachial index (ABI) when indi-
ated, photography of the ulcer with measurements of area
ecorded using a dedicated wound software system
Wound Expert), and duplex ultrasound of the superficial,
eep, and perforating veins. Arterial disease was corrected
y endovascular or bypass procedures. All superficial veins,
ncluding saphenous veins and tributaries, that were dilated
o 3 mm and showed reflux, were treated with either
ndovenous ablation or microphlebectomy. Patients had
ndovenous ablations and procedures on the tributary veins
s well as skin grafts. When these procedures failed to heal
r improve the venous ulcer over 3 months of closely
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rator incompetence.
Ulcer management prior to endovenous ablation.
Patients underwent treatment in our dedicated wound care
center for a minimum of 3 months and a mean of 34
months prior to endovenous ablation of incompetent per-
forator veins. In addition to twice weekly three and four
layer compression therapy, patients had debridement, top-
ical and systemic antibiotic treatment, topical growth fac-
tors, and skin substitutes. When patients completed 3
months of compression therapy, those with persistent ul-
cers that did not show evidence of healing by measurement
using the software system underwent repeat duplex ultra-
sound to re-evaluate for any remaining reflux in the super-
ficial system, and if none were found, to specifically evaluate
the limb for incompetent perforating veins. Incompetent
perforators in the medial ankle and calf, high calf, paratibial
region, thigh, and lateral leg were investigated in a sitting
position, using a reflux time of1 second and a diameter of
3 mm as criteria for perforator incompetence. Patients
with incompetent perforating veins were offered en-
dovenous ablation to treat their perforator reflux and po-
tentially heal their venous ulcer.
Endovenous ablation technique. The technique for
ablation was based on publications describing the en-
dovenous radio-frequency perforator ablation technique7
and the IFU for the VNUS Closure RFS device (VNUS
Medical Technologies, San Jose, Calif), specifically de-
signed for ablation of perforating veins. The procedures
were performed by four vascular surgeons, although one
performed90% of the procedures. The patient was placed
in reversed Trendelenburg position on an electronic tilt
table and a GE Logiq e portable duplex scanner (GE
Healthcare Technologies, Waukesha, Wisc) was used for
duplex imaging by the operating surgeon. The incompe-
tent veins had been previously identified in a vascular
laboratory and were confirmed by the surgeon prior to the
procedure. Once the incompetent veins were marked, the
leg was then prepped sterilely for the procedure. Using an
ultrasound transducer of 12 MHz, covered with a sterile
sheath, the incompetent perforating veins immediately
above the ulcer were selected for initial treatment.
We used the stylet from the RFS catheter to puncture
the skin, if it was malleable. When it was hard and/or
calcified, we used a no. 11 blade to puncture the skin,
followed by the RFS catheter. The stylet was advanced at a
45 degree angle, and the transducer was rotated 90 degrees
to confirm position in each plane as the stylet was advanced
to the junction of the perforator vein and the fascia. An
attempt was made to puncture the wall of the vein at the
level of or immediately below the fascia. Although aspira-
tion of blood was the goal, it was not always achieved. Once
the location of the catheter was confirmed, the stylet was
removed, the catheter position again confirmed, and the
catheter was then surrounded with lidocaine, which was
injected along the catheter with a 25 g needle to the level of
the fascia. The patient was then placed in Trendelenburg
position, the position of the catheter was again confirmed, rnd the vein was then treated with radio-frequency energy,
sing 1 minute of treatment in each quadrant, while im-
edance and temperature were kept within the therapeutic
ange (400 and at 85°C, respectively). A second level of
blation, using a similar technique, was often performed in
he vein above the fascia. Although an attempt was made to
onfirm successful ablation postprocedure, the lidocaine in
he region of the perforator frequently caused an appear-
nce of occlusion, even when the compression was from
uid extrinsic to the vein. After removing the catheter, the
eg was dressed with a three or four layer compression
ressing.
Confirmation of closure of the perforating vein was
btained at the next wound care visit by a vascular labora-
ory technician who was not involved in the procedure and
rovided an independent assessment of successful ablation.
erforator closure was defined as no blood flow in a previ-
usly incompetent perforator vein, demonstrated in a sit-
ing or standing position, by duplex ultrasound.
ESULTS
Between April 4, 2007 and September 9, 2010, 208
atients had venous ulcers treated in our wound care cen-
er; 86 were managed with compression therapy, 77 pa-
ients were treated with a superficial procedure alone, and
5 had perforator ablation. The 45 patients had 75 non-
ealing venous ulcers for 3 months in 51 limbs; all
atients had CEAP 6 clinical classification on entry into the
tudy. Patients ranged in age from 35 to 93, with a mean
ge of 74 (SEM  1.85) and had a mean body mass index
BMI) of 31 (SEM  1.21 range 19-45) (Table I). The
ocation of the ulcers was medial ankle in 61%, calf in 37%,
nd lateral ankle in 2%. The etiology of the venous ulcer was
ostphlebitic in 31% and of unknown etiology in 69%; one
atient had venous obstruction as well as reflux. The num-
er of incompetent perforating veins ranged from one to
ve in each leg with a venous ulcer. Patients had their ulcer
or a mean of 93 months (range 1-300 months). The
verage diameter of incompetent perforator was 4.3 mm.
wenty-one patients had deep venous reflux; 10 were
ost-thrombotic; 12 patients with 13 lower limb ulcers had
eripheral arterial disease, and eight limbs underwent arte-
able I. Demographic variables in patients undergoing
ndovenous perforator ablation
Variable
Mean age (years) 74
Mean BMI (kg/m2) 31
Sex (male: female) 26:19
ABI (0.9) 29%
Anticoagulation therapy 33%
Previous DVT 31%
Deep venous reflux 46%
Diabetes mellitus 18%
BI, Ankle-brachial index; BMI, body mass index; DVT, deep vein throm-
osis.ial revascularization. Patients had undergone procedures
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Volume 54, Number 3 Lawrence et al 739at other institutions to treat the venous ulcers, including
four great saphenous vein strippings, two small saphenous
vein strippings, and one surgical procedure on a perforating
vein (Table II). Patients had concomitant diseases that
might interfere with wound healing, including three pa-
tients with chronic liver disease, two undergoing chemo-
therapy for a neoplasm, one immunosuppressed for sys-
temic lupus erythematosus, one with leg edema due to
congestive heart failure, one with renal insufficiency that
was dialysis dependent, and one with sickle cell disease.
Prior to consideration of endovenous perforator ablation,
patients underwent multiple procedures at UCLA to heal
their wounds, and many had been performed years prior to
the procedure (Table III). Patients did not undergo an
endovenous perforator ablation unless they had at least a
3-month period of intensive wound care without ulcer
healing after one of these procedures and had eliminated all
sources of superficial veins reflux, which was confirmed by
duplex ultrasound. Ten patients had perforator reflux doc-
umented, yet did not undergo a procedure due to insurance
company denial.
Endovenous ablation results. Ablation was initially
successful in 58% of incompetent perforator veins and 12%
additional ablation procedures were performed at a mean of
193 days (range 27-746 days) (Fig 1); overall, the final
closure rate was 71%. There was a learning curve with the
procedure, and the success improved over time from 56% to
79% (Fig 2). The closure success was independent of the
site of the perforator, BMI of the patient, or age of the
ulcer. Average of ulcer size before the first successful radio-
frequency ablation was 12 cm with SEM 2.53 cm. Ulcers
healed in patients with successful ablation of at least one
perforator in 90%, at a mean of 138 days (range 60-365);
six ulcers never healed. The nonhealing ulcers had a mean
Table II. Procedures performed before referral to UCLA
Procedure Number
Vein stripping (4 GSV & 2 SSV) 6
Perforator procedure 1
Vein ligation/phlebectomy 0
GSV, Great saphenous vein; SSV, small saphenous vein.
Table III. Procedures performed at UCLA prior to
perforator ablation
Procedure Number
Tributary vein ligation 13
Vein stripping (6 GSV & 5 SSV) 11
SEPS 7
Great saphenous vein ablation 16
Small saphenous vein ablation 5
Skin graft 14
GSV, Great saphenous vein; SEPS, subfascial endoscopic perforator surgery;
SSV, small saphenous vein.diameter of 6.5 cm and a mean age of 127 months. aAll patients who healed ulcers had at least one incom-
etent perforator closed by ablation; no patient had wound
ealing without at least one successful perforator ablation.
he average follow-up was 12.85 months with (SEM 
.48 months) 4% of healed ulcers recurred (two ulcers in
ne patient) probably because of common iliac vein ob-
truction. There were no complications associated with the
erforator ablation, such as wound infection, skin necrosis,
r nerve injury.
ISCUSSION
Ambulatory superficial venous hypertension secondary
o reflux in the deep, superficial, and perforating veins of
he leg is the accepted pathogenesis of most venous ul-
ers,1,8,9 although venous hypertension may also occur due
o venous obstruction.10 Local cellular changes in the
issues occur secondary to the venous hypertension, and
nclude white cell mediated inflammation and fibrin cuffs.10
he most common identifying etiology of venous incom-
etence results from changes in the vein valves and walls
ollowing deep vein thrombosis (DVT) that renders the
alves incompetent. Once ambulatory venous hypertension
ccurs, lipodermatosclerosis may develop and eventually
enous ulceration occurs, although this process can be
elayed or prevented by leg compression. Once venous
lceration occurs, healing of the tissue can best be accom-
lished by reducing leg edema and superficial venous hy-
ertension. The initial approach is typically compression of
he skin and subcutaneous tissue with multilayered dress-
ngs, which is effective for most patients. However, some
ontinue to have progressive lipodermatosclerosis and are
nable to heal venous ulcers when they occur. If refractory
lceration occurs, imaging with duplex ultrasound can
dentify the location of refluxing or obstructed veins, and
hysiologic studies can quantify the degree of reflux. When
ompression fails to heal venous ulcers, therapeutic options
ocus on preventing superficial vein and perforator reflux
nd occasionally correcting deep valvular reflux. Most in-
estigators have favored correction of the superficial reflux
nitially by removing or ablating the refluxing saphenous
eins and tributaries, since these procedures are relatively
imple and effective and will heal many venous ulcers.2,11,12
hen superficial ablation does not result in venous ulcer
ealing, perforator interruption is usually the next step.
hether it is done with direct surgery, sclerotherapy, sub-
ascial endoscopic perforator surgery (SEPS), or en-
ovenous ablation, the elimination of perforator reflux
educes ambulatory venous hypertension. Minimally inva-
ive techniques are being used more frequently, since they
re associated with fewer wound complications from the
rocedure. There are few papers that address success rates
or ablation; we had a lower success rate, but also a much
ower complication rate.3,13
In our study, patients underwent not only optimal
ound care and compression for their ulcers, but also had
efluxing superficial veins treated with ablation and liga-
ion, and yet they were unable to heal their ulcers. The
verage period of wound care was 3 years in our center,
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made before perforator ablation was offered to the patients.
Consequently, the only remaining option is perforator
Fig 1. A, The location of incompetent perforating vein
represents a refluxing perforating vein. B, After the initia
C, After the second ablation procedure, additional veins
Fig 2. A, Learning curve of a single vascular surgeon. B
for our center is shown here over a 4-year period.ablation; there are two minimally invasive approaches to terforator ablation, sclerotherapy, and endovenous ther-
al ablation. We have had little experience with perforator
clerotherapy, but are concerned about the risk of reflux of
atients with recalcitrant venous ulcers. Each open circle
tion procedure, the black circles represent ablated veins.
closed, as noted in this diagram.
forator closure success rate. The successful ablation rates in p
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Volume 54, Number 3 Lawrence et al 741DVT.14 The endovenous ablation of perforators seems to
have a more predictable outcome with a lower risk.
We learned several important principles from this
study. First, the selection of appropriate patients is critical
to maximize the impact of perforator ablation. There are
patients who are unable to heal their venous ulcers after
many years of compression, in spite of excellence compli-
ance with recommended therapy. It is this group of patients
who are most likely to benefit from ablation of incompetent
perforator veins. When we encounter a patient with venous
ulcers who demonstrates compliance with recommended
compression therapy over a period of more than 3 months
under direct supervision, we have found that the likelihood
of later healing is low. Consequently, we try to identify all
incompetent superficial and perforating veins that might be
contributing to ambulatory venous hypertension and at-
tempt to correct the incompetence with ablation of reflux-
ing veins. Due to the high success of ablation of saphenous
veins and other axial veins, which in our experience is
99%,15 we correct them first. We also ligate or perform
microphlebectomy on incompetent tributary veins that re-
flux into the area of the ulcer, although we are reluctant to
make incisions into skin with lipodermatosclerosis, since
wound healing can be a problem. Once all other causes of
venous reflux are dealt with, if the ulcer remains nonheal-
ing, we investigate for incompetent perforating veins by
repeating the duplex ultrasound. For medial ankle venous
ulcers, we focus on the region of the posterior tibial upper,
mid, and lower groups. For lateral ankle ulcers, we focus on
the lateral calf and ankle perforators. If no incompetent
perforating veins are found in these regions, we then look
for paratibial veins, the 24 cm perforating vein, and even
thigh perforating veins that are grossly dilated, incompe-
tent, and reflux through tributary veins into the area of the
venous ulcer.
Several recent studies have emphasized the role of
venous obstruction in the development of venous ulcers.16
Currently, we limit our evaluation of patients with nonheal-
ing venous ulcers to duplex ultrasound of the leg and thigh,
up to the common femoral vein and distal external iliac
vein, and do not extend the evaluation to the entire iliac
system, using either contrast venography, computed to-
mography (CT), or magnetic resonance (MR) venography,
although we do look for obstruction of the deep venous
system in the femoral vein and the popliteal vein, using
duplex ultrasound. In this series of venous ulcers, one
patient had obstruction of the proximal deep venous sys-
tem, and he failed to heal his ulcer, even after successful
perforator ablation. We had decided to investigate for
proximal obstruction, as recommended by Raju and Hin-
gorani, since their reports indicate that correction of prox-
imal obstruction can heal venous ulcers, even when they
have reflux.13,16
Patients who have either healed ulcers (CEAP 5) or
lipodermatosclerosis (CEAP 4) were not included in this
study, although we have encountered many CEAP 4/5
patients who have reflux in the perforating veins. We cur-
rently are looking at outcomes in these patients to deter- sine if ablation of incompetent perforating veins will slow
he progression of lipodermatosclerosis or prevent recur-
ent ulceration. Until this issue is resolved, we do not
ecommend ablation of perforating veins for CEAP 4 or 5
isease but do recommend lifetime compression with qual-
ty support hose.
Second, we learned that this is a technically difficult
rocedure with the current ablation devices and has a
ignificant learning curve. In our study, the learning went
n over 4 years and benefited from the relatively large
umber of patients with venous ulcers. For an individual
urgeon who does not have a large venous practice, the
earning curve may be longer than ours. It takes patience
nd a significant number of procedures to be sure that the
tylet and catheter are in the perforating vein at the level of
he fascia. There is a very short-distance between the skin
nd the tibial nerves and arteries, so placement must be
ore precise than with ablation of the saphenous system.
e believe that a goal of 80% procedural success is achiev-
ble for most surgeons, although many will start out at 50%
o 60%. However, even when ablation fails to close the
erforator vein, the procedure can be repeated with good
uccess, and the complications of failure are rare. We be-
ieve that a second and even third procedure is justified in
hese patients.
We have debated how many incompetent perforators
hould be closed at a single sitting and currently believe that
he best approach is to pick the incompetent perforator
eins immediately adjacent to and above the ulcer—ones
hat are likely to reflux into the ulcer when the patient is
itting or standing as the initial veins for closure. Once
hese veins are closed, then a search for other large
ncompetent perforating veins in the region should be
ade. Frequently, other nearby perforators will be diffi-
ult to visualize once the first perforator has been ablated
ue to the infiltration of lidocaine throughout the adja-
ent tissue. If refluxing and close to the ulcer, a second
ncompetent vein should also be considered for ablation.
Since this was not a prospective, randomized study, it
oes not provide unequivocal evidence of the benefit of
erforator ablation, although it is highly suggestive. Using
atients as their own controls and subjecting them to a
ead-in phase with a mean time of 3 years, where we
ttempted to heal their ulcers under direct observation in a
ery experienced wound care setting, indicates that these
lcers were very unlikely to heal without some other mod-
fication, such as weight loss, better nutrition, or elimina-
ion of the dependent position by strict bed rest. For most
atients, these options are not achievable, so the patients
e treated were presented with either prolonged wound
are or procedures to ablate refluxing veins. The only other
ption of excision of the ulcer with ligation of the refluxing
eins in the ulcer bed, followed by a skin graft, has been
eported by other authors17 but this option was not offered
o our patients.
The most compelling argument that perforator abla-
ion facilitates ulcer healing is that we had no patient in our
eries who healed an ulcer following failed ablation, so
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ance was only successful when at least one perforator was
closed. In addition, when at least one perforator was closed,
a very high percentage of patients (90%) had complete
healing of their ulcer.
CONCLUSIONS
This experience with ablation of CEAP 6 nonhealing
venous ulcers demonstrates both the feasibility and effec-
tiveness of perforator ablation in patients who fail a
3-month trial of compression therapy. After superficial
refluxing saphenous and tributary veins have been treated,
those patients who are still unable to heal their venous
ulcers with compression and local wound care benefit from
perforator ablation. The technique of ablation has a signif-
icant learning curve, but complications are uncommon and
repeated ablation until at least one incompetent perforator
has been closed results in a healing rate of 90% and no
recurrent ulcers over the short-term in patients who are
compliant with compression therapy. We recommend per-
forator ablation after all other forms of therapy have failed
for patients with recalcitrant venous ulcers.
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